XML 48 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Statements of Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Research and development expenses $ 6,323 $ 7,320 $ 8,183
General and administrative expenses 4,185 4,063 5,375
Sales and marketing expenses 754 746 1,328
Other expenses (income) 5 4 7
Operating loss 11,267 12,133 14,893
Interest income from deposits (172) (318) (192)
Finance expenses (income), net (42) (529) 275
Loss before tax 11,053 11,286 14,976
Taxes on income
Total comprehensive and net loss $ 11,053 $ 11,286 $ 14,976
Net loss per ordinary share, basic (in Dollars per share) $ (0.6) $ (0.93) $ (1.39)
Net loss per ordinary share, diluted (in Dollars per share) $ (0.6) $ (0.93) $ (1.39)
Weighted average number of ordinary shares outstanding basic (in Shares) 18,515,545 12,095,477 10,794,594
Weighted average number of ordinary shares outstanding diluted (in Shares) 18,515,545 12,095,477 10,794,594